Algernon Pharmaceuticals Inc (AGNPF)

[DiamondInTheRough]

With regards to your question of what they will be trial testing, this is a snippet from the Company Overview that was released on Monday:

NaNose Technology:
The Company anticipates receiving requisite IRB regulatory approval in order to commence clinical studies in Surrey, BC, Canada this month. The study has been designed to determine if the NaNose technology can identify differences in the breath signatures of patients with bacterial infections versus patients with viral infections. The ability to differentiate between bacterial versus viral infections at the Point of Care is anticipated to greatly assist physicians with treatment recommendations which could significantly and positively impact the excessive prescribing and resulting overuse of antibiotic-based treatments